167 related articles for article (PubMed ID: 12235860)
1. [Combination use of kampo-medicines and drugs affecting intestinal bacterial flora].
Ishihara M; Homma M; Kuno E; Watanabe M; Kohda Y
Yakugaku Zasshi; 2002 Sep; 122(9):695-701. PubMed ID: 12235860
[TBL] [Abstract][Full Text] [Related]
2. [Intestinal microbiota and Kampo medicine].
Ohta K; Kitajima M
Rinsho Byori; 2009 Jun; 57(6):542-8. PubMed ID: 19621786
[TBL] [Abstract][Full Text] [Related]
3. Effects of furanocoumarins in Kampo extract-based medicines on rat intestinal absorption of CYP3A and P-glycoprotein substrate drugs in vivo.
Iwanaga K; Arimune K; Miyazaki M; Shibano M; Taniguchi M; Baba K; Kakemi M
Arch Pharm Res; 2012 Jun; 35(6):1055-64. PubMed ID: 22870815
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of Kampo medicine on human UGT2B7 activity.
Nakagawa N; Katoh M; Yoshioka Y; Nakajima M; Yokoi T
Drug Metab Pharmacokinet; 2009; 24(6):490-9. PubMed ID: 20045984
[TBL] [Abstract][Full Text] [Related]
5. [An analysis of the ingredients in decoctions and extracts of Kampo medicines: Amounts of baicalin and baicalein in Kampo medicines containing Scutellariae Radix].
Shii T; Kuroda M; Shamoto N; Mimaki Y
Nihon Ronen Igakkai Zasshi; 2020; 57(1):72-80. PubMed ID: 32074563
[TBL] [Abstract][Full Text] [Related]
6. Toxicological considerations of Kampo medicines in clinical use.
Ikegami F; Fujii Y; Satoh T
Toxicology; 2004 May; 198(1-3):221-8. PubMed ID: 15138045
[TBL] [Abstract][Full Text] [Related]
7. Effect of Schisandrae Fructus on glycyrrhizin content in Kampo extracts containing Glycyrrhizae Radix used clinically in Japan.
Nose M; Tada M; Kato A; Hisaka S; Masada S; Homma M; Hakamatsuka T
J Nat Med; 2019 Sep; 73(4):834-840. PubMed ID: 31165408
[TBL] [Abstract][Full Text] [Related]
8. Effects of glycyrrhizin and glycyrrhetic acid on the growth, glycyrrhizin beta-D-glucuronidase and 3 beta-hydroxysteroid dehydrogenase of human intestinal bacteria.
Akao T
Biol Pharm Bull; 2000 Jan; 23(1):104-7. PubMed ID: 10706421
[TBL] [Abstract][Full Text] [Related]
9. [Possibility of interactions between prescription drugs and OTC drugs (2nd report)--interaction between levodopa preparation and OTC Kampo medicines for upset stomach].
Sunagane N; Aikawa M; Ohta T; Uruno T
Yakugaku Zasshi; 2006 Nov; 126(11):1191-6. PubMed ID: 17077621
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use.
Ikegami F; Sumino M; Fujii Y; Akiba T; Satoh T
Hum Exp Toxicol; 2006 Aug; 25(8):481-94. PubMed ID: 16937920
[TBL] [Abstract][Full Text] [Related]
11. Kampo medicines as alternatives for treatment of migraine: six case studies.
Ishida K; Sato H
Complement Ther Clin Pract; 2006 Nov; 12(4):276-80. PubMed ID: 17030300
[TBL] [Abstract][Full Text] [Related]
12. Toxicological aspects of Kampo medicines in clinical use.
Ikegami F; Fujii Y; Ishihara K; Satoh T
Chem Biol Interact; 2003 Jun; 145(3):235-50. PubMed ID: 12732452
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the interactions between Chrysanthemum morifolium flowers extract and intestinal bacteria from human and rat.
Tao JH; Duan JA; Qian YY; Qian DW; Guo JM
Biomed Chromatogr; 2016 Nov; 30(11):1807-1819. PubMed ID: 27151775
[TBL] [Abstract][Full Text] [Related]
14. Shosaiko-to and other Kampo (Japanese herbal) medicines: a review of their immunomodulatory activities.
Borchers AT; Sakai S; Henderson GL; Harkey MR; Keen CL; Stern JS; Terasawa K; Gershwin ME
J Ethnopharmacol; 2000 Nov; 73(1-2):1-13. PubMed ID: 11025134
[TBL] [Abstract][Full Text] [Related]
15. A review of traditional Japanese medicines and their potential mechanism of action.
Uezono Y; Miyano K; Sudo Y; Suzuki M; Shiraishi S; Terawaki K
Curr Pharm Des; 2012; 18(31):4839-53. PubMed ID: 22632864
[TBL] [Abstract][Full Text] [Related]
16. Glycyrrhizin stimulates growth of Eubacterium sp. strain GLH, a human intestinal anaerobe.
Akao T; Akao T; Kobashi K
Appl Environ Microbiol; 1988 Aug; 54(8):2027-30. PubMed ID: 3178209
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for pediatric chronic intestinal pseudo-obstruction: Nationwide survey in Japan.
Hashizume N; Yagi M; Ushijima K; Seki Y; Fukahori S; Muto M; Matsufuji H; Taguchi T
Pediatr Int; 2017 Apr; 59(4):467-472. PubMed ID: 27862707
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of anti-allergic effects mediated by the Kampo medicine Shoseiryuto (Xiao-Qing-Long-Tang in Chinese) with lysed Enterococcus faecalis FK-23 in mice.
Shimada T; Kondoh M; Motonaga C; Kitamura Y; Cheng L; Shi H; Enomoto T; Tsuruta D; Ishii M; Kobayashi H
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):59-66. PubMed ID: 20527518
[TBL] [Abstract][Full Text] [Related]
19. Effects of Kampo medicines on P-glycoprotein.
Satoh T; Watanabe Y; Ikarashi N; Ito K; Sugiyama K
Biol Pharm Bull; 2009 Dec; 32(12):2018-21. PubMed ID: 19952421
[TBL] [Abstract][Full Text] [Related]
20. [Research advance in metabolism of effective ingredients from traditional Chinese medicines by probiotics].
Dai CE; Li HL; He XP; Zheng FF; Zhu HL; Liu LF; Du W
Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(1):31-38. PubMed ID: 29552808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
